PMS39 Cost-Effectiveness Analysis of Certolizumab Pegol in Patients With Rheumathoid Arthritis From a Brazilian Private Perspective

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.1394
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search